Email Us Here

The NEI Awards $2.03 Million Commercialization SBIR Grant to Aciont

The National Eye Institute (NEI) awarded a $2.03 million phase IIB grant to Aciont Inc. to fund the clinical development of a non-invasive, passive diffusion-based treatment for uveitis (referred to as DSP-Visulex-TM).